News & Updates
Showing Urology articles
Showing
Show Multimedia Only

More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
09 May 2024
byKanas Chan
Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide reported more fatigue, depression and deterioration in perceived cognitive ability, and slower reaction time than those receiving abiraterone acetate, according to results of the ACE study.
09 May 2024

NCHT improves PFS in locally advanced prostate cancer
06 May 2024
byStephen Padilla
Neoadjuvant chemohormonal therapy (NCHT) plus radical prostatectomy (RP) confers significant biochemical progression-free survival (bPFS) benefits relative to neoadjuvant hormonal therapy (NHT) plus RP on patients with high-risk, locally advanced prostate cancer, reports a study.
06 May 2024







